Table 2.
Comparison of primary clinical data between patients with BCS duration time less than one year and BCS duration time more than one year.
| n | BCS duration time | P | ||
|---|---|---|---|---|
| <1year (n=55) | >1year (n=58) | |||
| Age | 49.5 ± 14.5 | 48.9 ± 14.5 | 0.83 | |
| Gender | 0.08 | |||
| male | 73 | 31 | 42 | |
| female | 40 | 24 | 16 | |
| Hepatic venous outflow tract obstruction subtype | 0.60 | |||
| obstruction of IVC | 50 | 27 | 23 | |
| hepatic vein occlusion | 13 | 6 | 7 | |
| Mixed type | 50 | 22 | 28 | |
| HBsAg | 0.67 | |||
| positive | 5 | 3 | 2 | |
| negative | 108 | 52 | 56 | |
| Laboratory examination | ||||
| ALT | <0.01 | |||
| <40 U/L | 87 | 34 | 53 | |
| >40 U/L | 26 | 21 | 5 | |
| AST | 0.02 | |||
| <40 U/L | 78 | 32 | 46 | |
| >40 U/L | 35 | 23 | 12 | |
| Total bilirubin | 0.82 | |||
| <21 μM/L | 44 | 22 | 22 | |
| >21 μM/L | 69 | 33 | 36 | |
| albumin | 0.31 | |||
| >35 g/L | 79 | 36 | 43 | |
| <35 g/L | 34 | 19 | 15 | |
| PT-INR | 0.99 | |||
| <1.2 | 74 | 36 | 38 | |
| >1.2 | 39 | 19 | 20 | |
| PLT | 0.79 | |||
| >100*1012/L | 59 | 28 | 31 | |
| <100*1012/L | 54 | 27 | 27 | |
| WBC | 0.79 | |||
| >4*109/L | 61 | 29 | 32 | |
| <4*109/L | 52 | 26 | 26 | |
| Hb | 0.76 | |||
| >131 g/L | 62 | 31 | 31 | |
| <131 g/L | 51 | 24 | 27 | |
| Hepatic encephalopathy | 0.74 | |||
| + | 9 | 5 | 4 | |
| – | 104 | 50 | 54 | |
| ascites | <0.01 | |||
| + | 49 | 33 | 17 | |
| – | 64 | 23 | 41 | |